Pharma Industry News
A collection of Pharma latest news, analysis and best practices from top business influencers and the world's most trustworthy sources.
Nikkei Rises 1.0%, Led by Pharma, Machinery Stocks
0015 GMT — Japanese stocks are higher, supported by bargain-hunting, as recent rising momentum in crude oil eases. Pharmaceutical and machinery stocks are leading gains. Eisai is up 2.4% and is 3.2% higher. The dollar is at 155.87 yen, up…
Exclusive: After Survey Flags 2,800% Pharma Profit, Tukaram Mundhe Calls For Transparency
'Basically there has to be a fair trade, fair margin of profit.,' Tukaram Mundhe said. Summary is AI-generated, newsroom-reviewed Maharashtra FDA found up to 2800% profit margin on IV sets sold to hospitals and consumers Maharashtra FDA wrote to…
Zealand Pharma A/S (ZLDPY) Presents at Morgan Stanley 24th Annual Global Healthcare Conference Transcript
Zealand Pharma A/S (ZLDPY) Morgan Stanley 24th Annual Global Healthcare Conference September 16, 2026 11:30 AM EDT Adam Steensberg - President & CEO Cool. Well, thank you all for being here. I'm James Machin from the Morgan Stanley banking team and…
Could Palestinian pharma companies supply Israel? Time to test it
More than three decades ago, the Oslo framework identified pharmaceuticals as one area for Israeli-Palestinian industrial cooperation. That idea is worth revisiting today, not because economic cooperation can resolve the Israeli-Palestinian…
Innate Pharma Q2 Earnings Call Highlights
Innate Pharma NASDAQ: IPHA said its first-half 2026 developments included the closing of a strategic partnership with Sobi for lacutamab, completion of dose-escalation enrollment for IPH4502, and completed enrollment in the PACIFIC-9 phase III…
Urogen Pharma (NASDAQ:URGN) Receives Average Recommendation of 'Moderate Buy' from Analysts
Urogen Pharma (NASDAQ:URGN - Get Free Report) has earned a consensus rating of 'Moderate Buy' from the ten research firms that are covering the company, MarketBeat reports. One research analyst has rated the stock with a sell rating, one has issued…
BTIG Research Reaffirms Buy Rating for Innate Pharma (NASDAQ:IPHA)
Innate Pharma (NASDAQ:IPHA - Get Free Report)'s stock had its 'buy' rating restated by equities researchers at BTIG Research in a note issued to investors on Thursday, Benzinga reports. They presently have a $9.00 price objective on the stock. BTIG…
Avalyn Pharma (NASDAQ:AVLN) Shares Down 4.4% - Here's What Happened
Avalyn Pharma Inc. (NASDAQ:AVLN - Get Free Report) shares were down 4.4% during trading on Thursday. The company traded as low as $33.20 and last traded at $33.20. Approximately 42,641 shares were traded during mid-day trading, a decline of 86%…
Baird Financial Group Inc. Buys New Position in Ascendis Pharma A/S $ASND
Baird Financial Group Inc. purchased a new position in Ascendis Pharma A/S (NASDAQ:ASND - Free Report) during the second quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The…
Tarja Stenvall Appointed Chief Executive Officer of Bavarian Nordic
COPENHAGEN, Denmark, September 17, 2026 – Bavarian Nordic A/S (OMX: BAVA) today announced that Tarja Stenvall has been appointed President and Chief Executive Officer, effective October 15, 2026, succeeding Paul Chaplin whose departure was…
This Trend is Excellent News for Eli Lilly and Its Investors
Eli Lilly (LLY +0.15%) is the global leader in one of the hottest growth markets on the planet: the weight loss drug market. The pharma giant holds 60% of the U.S. market, while its closest rival, Novo Nordisk (NVO -1.93%), has about 38% share.
Cathay Pacific, HK Express carry a record of more than 3.6 million passengers in Aug
Cathay Pacific and budget airline HK Express carried a record number of over 3.6 million passengers in August despite elevated jet fuel prices, driven by robust travel demand during the summer peak. SCROLL TO CONTINUE WITH CONTENT Flagship carrier…
There's a biotech stock on Josh Brown's list that's ignoring the market noise and pushing higher
(This is The Best Stocks in the Market, brought to you by Josh Brown and Sean Russo of Ritholtz Wealth Management.) Josh — Ladies and gentlemen, we interrupt this moment of existential threats from advanced AI models and Federal Reserve…
Markets steady after Fed rate hike; mixed trend across indices
Markets held their ground Thursday even as the U.S. Federal Reserve delivered its first interest-rate increase since 2023, raising borrowing costs by 25 basis points and signalling at least one more hike this year, a move that rattled currencies…
Technology Transfer Has A Data Problem, Not A Process Problem
Dr. Siva Samy is the founder and CEO of ValGenesis, an inventor with 8 patents in digital and AI-based validation, and a Ph.D in Pharma. Technology transfer is one of the most critical processes in life sciences manufacturing. It is also…
Receive a Daily briefing on Pharma Industry News
Get Started